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Abstract
Poor quality medicines represent an expanding global public health threat facilitated by the Internet. A recent
survey showed that one in five students have used modafinil to enhance learning ability mainly purchased
from Internet sources. The aim of this work was to develop on-the-spot and simple methods for the
quantification of modafinil in generic medicines using Fourier transform-infrared (FTIR), near-infrared (NIR) and
Raman spectroscopy along with partial least square regression (PLSR). Modafinil tablets were measured in
intact form using NIR and Raman and in powdered form using FTIR, NIR and Raman. Additionally, powder
mixtures of crushed modafinil tablets and excipient(s) were prepared either by diluting the crushed tablets
with excipient(s), or sequentially adding excipient(s) to the crushed tablets. Three PLSR models were
constructed in MATLAB 2014a from powder mixtures and two from intact and powdered tablets. For FTIR
and Raman spectroscopy, PLSR models based on tablets gave linear calibration curve with correlation
coefficient (r2) values above 0.94 and a root mean square error of calibration (RMSEC) below 0.96% m/m.
Conversely, the PLSR model based on powder sequential addition gave the highest accuracy using the NIR
spectra (r2 = 0.99, RMSEC = 1.15% m/m). The latter model showed accuracy in predicting the concentration
of the active pharmaceutical ingredient in modafinil generic medicines proving their authenticity. The overall
results showed that the combination of the three spectroscopic methods with PLSR offered a rapid technique
for authenticating generic modafinil medicines.
Keywords: Counterfeit medicines, Infrared, Near-infrared, Raman, Spectroscopy, Quantification, Authentication,
Partial least square regression
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Introduction
Poor quality medicines represent a global threat to the
public health that can result in treatment ineffectiveness,
drug resistance, increased morbidity and mortality rate,
economic loss and problems to the healthcare system
(Gaurvika et al. 2019; Janvier et al. 2018). Poor quality
medicines can be degraded, substandard or counterfeit
medicines (Mukhopadhyay 2007). Degraded medicines
include those, which deteriorate from the poor-quality
storage (humidity, temperature and light). Substandard
medicines are those that encounter accidental defects in
the manufacturing process and fail to fulfil the products’
specifications. Counterfeit medicines are medicines
which “are deliberately and fraudulently mislabelled with
respect to identity and/or source” (WHO Medicines
2012).
The Internet plays a major role in the spread of poor
quality medicines, which could be over the counter
products, prescription medicines, drugs of abuse and
supplementary products (FDA The possible dangers of
buying medicines over the Internet 2014; Fittler et al.
2013; Orizio et al. 2011). This is partly due to the fact
that the market of counterfeit online medicines is in
continuous expansion (Orizio et al. 2009). According to
the World Health Organisation (WHO), 50% of the
medicines sold through illegal online pharmacies are
counterfeits (WHO Counterfeit medicines 2006). Thus,
in 2013, the Interpol closed down over 9600 illegal
online pharmacies and seized over 9.6 million prescrip-
tion medicines that were worth over $41.1 million
(Safemedicines 2013). In this respect, the purchase of a
counterfeit medicine could impose a public safety issue
especially in case of drugs of abuse where medicines are
frequently bought online.
Smart drugs represent one of the top classes that sales
have increased (up to 50%) over the last decade and has
been facilitated by the Internet (International Narcotics
Control Board 2016). Smart Drugs such include nootro-
pics that have become particularly popular among stu-
dents and healthcare professionals who have been under
pressure of study/work (Champagne et al. 2019; Inter-
national Narcotics Control Board 2016). Students and
healthcare professionals have utilised nootropics for en-
hancement of the memory and learning abilities (Baskys
and Remington 1996; Turner et al. 2003; Gold and
Balster 1996). There are several different nootropics on
the market, e.g. adderall, dexedrine, ephedrine, methyl-
phenidate, modafinil and piracetam. Modafinil has the
same stimulant effects of nootropics; however, it has less
abusive tendencies and side effects (Baskys and Reming-
ton 1996; Turner et al. 2003).
Modafinil is sold under the brand name Provigil
(Young-Powell and Page 2014) and comprises modafinil
as the active pharmaceutical ingredient (API) and the
following excipients: croscarmellose sodium, lactose
monohydrate, magnesium stearate, maize starch and
povidone. Nonetheless, the excipients in generic modafi-
nil are not always known, and this variation influences
the process of authentication of branded and generic
modafinil. Thus, when authenticating a branded medi-
cine, the test medicine needs to match the physical and
chemical properties of the reference medicine (The
Medicines Compendium Modafinil Provigil 100 mg
Tablets 2020). Generic medicines however only need to
prove that they contain the exact API at the correct con-
centration in relation to the reference medicine (Assi
et al. 2012). Consequently, a quantitative approach in
authenticating generic modafinil medicines is favoured.
The literature reported conventional methods for
quantification of the API in modafinil, which range from
simple spectrophotometric to chromatographic methods.
A spectrophotometric method was reported for the
quantification of modafinil in solid dosage forms and
underlined measurement of the absorbance of modafinil
at its maximum wavelength (236 nm) (Moffat et al.
2009). Chromatographic methods utilised mainly reverse
phase high performance liquid chromatography (RP-
HPLC) (Moffat et al. 2009; Venkatesh et al. 2011; Nages-
wara Rao et al. 2007; Cass et al. 2001), and thin layer
chromatography (TLC) (Xu et al. 2002). The aforemen-
tioned techniques offered sensitivity, selectivity and pre-
cision yet they were time-consuming, destructive and
required extensive sample preparation. On the contrary,
spectroscopic techniques including Fourier transform-
infrared (FTIR), near-infrared (NIR) and Raman spec-
troscopy have shown to be quicker, simpler and mobile
(Faisall et al. 2009; Assi et al. 2011a; Assi et al. 2011b;
Caporaso et al. 2018; Bouyé et al. 2018; Correia et al.
2018; Yang et al. 2019; Fedchak 2014; Crocombe 2018;
Gerace et al. 2019). When combined with multivariate
regression analysis, spectroscopic techniques offered
rapid, on-spot and non-destructive quantification of
APIs medicines (The Medicines Compendium Modafinil
Provigil 100 mg Tablets 2020; Crocombe 2018). To the
best of our knowledge, no spectroscopic methods have
yet been employed for quantification of modafinil in
tablets.
Therefore, this work aimed at developing methods for
the on-spot quantification of modafinil in generic medi-
cines using FTIR, NIR and Raman spectroscopy along
with partial least square regression (PLSR).
Materials and methods
Materials
Standard reference material including glucose, lactose,
magnesium stearate, maize starch, microcrystalline cellu-
lose, modafinil, povidone, sodium carboxymethylcellu-
lose and sucrose were purchased from Sigma-Aldrich.
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Eight modafinil generic batches of doses 100 and 200
mg were bought from four Internet websites (Table 1).
The percentage mass per mass (% m/m) of modafinil in
the tablets was in the range of 57.6–72.7% m/m.
Reference analysis of modafinil API and tablets was
performed using reverse phase-high performance liquid
chromatography (RP-HPLC) by adopting the procedure
given by Rao et al. 2007 (Rao et al. 2007).
Sample preparation
Four types of samples were considered in this study. The
first type included intact tablets, which were removed
from the packaging and used ‘as received’ without any
treatment. The second type comprised powdered tablets
which had been crushed in a mortar, homogenised and
stored in 4 mm glass vials. The third type of samples
comprised powders of pure substances (API and excipi-
ents) and the fourth type included powdered mixtures
that were prepared by mixing crushed modafinil tablets
with excipient(s).
Three modafinil mixtures were prepared and included:
M1 (modafinil lactose dilution), M2 (modafinil excipi-
ents dilution) and M3 (modafinil excipients sequential
addition) (Table 2). M1 (modafinil lactose dilution) was
prepared by adding aliquots of lactose (major excipient
in modafinil tablets) to crushed modafinil tablets to get a
% m/m of modafinil in the range of 9.59–62.5% m/m.
Similarly, M2 was prepared by adding aliquots of differ-
ent excipients (one at a time) to crushed modafinil
tablets to get 15.4–52.9% m/m of modafinil. A third
approach was adopted in mixtures (M3) which was
made by adding excipients (one at a time) sequentially
to aliquots of crushed modafinil tablets to get 15.9–
62.5% m/m.
Instrumentation
FTIR spectra were recorded using the Bruker Alpha
mobile-FTIR equipped with a single reflection pure
diamond attenuated total reflectance (ATR) crystal
sample interface. The spectral range of
the aforementioned instrument was 500–6000 cm−1.
NIR spectra were recorded employing the JDSU micro-
NIR 1700 pro-spectrometer equipped with linear vari-
able filter (LVF) dispersing element and 128-pixel cooled
InGaAs photodiode array detector. The NIR spectra
were measured over the wavelength range of 900–1700
nm. Raman spectra were recorded using the Rigaku
FirstGuard handheld Raman spectrometer equipped with
1064 nm laser power, thermoelectric cooling and charge
coupled device detector. Raman spectra were collected
over the wavenumber range of 250–2000 cm−1.
Spectroscopic measurements
For FTIR measurements, a few milligrams from pow-
dered samples or pure substances were measured by
placing them in direct contact with the ATR crystal.
Homogeneous preparations of samples were prepared
using a Vortex mixer before each measurement. Four
spectra were measured per sample such that a new
aliquot was changed after each measurement. Each
spectrum was the sum of 16 scans at a resolution of 4
cm−1. For NIR and Raman measurements, intact tablets
were measured ‘as received’ by placing them in direct
contact with the spectrometers. Four spectra were taken
from each tablet on both sides, such as two spectra were
taken from each side rotating the tablet after each meas-
urement. In addition, powders were measured through
glass vials (after mixing with Vortex mixer) by placing
them in direct contact with the instruments. Each
spectrum was the sum of 32 scans for NIR and 3 scans
for Raman, respectively.
Data treatment
Spectra from the three instruments were exported to
MATLAB 2014a for analysis. Spectral pre-treatment was
made using multiplicative scatter correction second
derivative (MSC-D1). The similarity between spectra was
assessed using correlation in wavelength space (CWS)
method. In this respect, a correlation coefficient (r) value
greater than or equal to 0.95 showed similarity. In
addition, quantitative models were developed using
PLSR. PLSR has been considered as ideal in this case
where univariate regression had not been possible.
This was because the absorbance and scattering in-
tensities in FTIR/NIR and Raman differed according
to the physicochemical properties of the measured
samples and not proportional to the concentration of
the analyte of interest (Burns and Ciurczak 2007). In
this respect, PLSR offered a multivariate approach for
quantifying the APIs in the aforementioned products.
PLSR models predicted the concentrations of the
different mixtures and/or products from multiple vari-
ables (absorbance intensities or scattering intensities
measured at the full wavelength range). PLSR models










1 1a 100 57.6
1 1b 100 62.9
2 2a 200 65.9
2 2b 200 72.7
3 3a 200 63.8
3 3b 200 66.3
4 4a 100 57.7
4 4b 100 62.8
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find components (latent variables) in the absorbance
and/or scattering intensities that relate to the concen-
trations. A PLSR model eventually assigns loadings
(small and large) to the aforementioned latent vari-
ables. Latent variables with small loadings are rejected
and vice versa. This is made by finding factors that
capture variation among the data such that each fac-
tor is added as one at a time. In this sense, the first
factor captures the highest variance, the second factor
the second highest variance and so on. The following
equations illustrate a PLSR model (Brereton 2003; Jee
2019):
X ¼ T :P þ E
c ¼ T :q þ f
Where
X is the absorbance or scattering intensities at different
wavelengths
c is the concentrations
q is the loading vector
T is the spectral score vector
p is the spectral loading vector
Results and discussion
The present study explored a swift quantification of
medicines purchased from several Internet sources using
handheld instruments. This was the first study that had
utilised quantitative PLSR models (non-destructive) with
portable handheld FTIR, NIR and Raman spectroscopy,
as well as a powder form of formulations with FTIR for
the quantification of modafinil in branded and generic
tablets. The aforementioned PLSR models were not only
limited to conventional dilution models but also in-
cluded more complex mixtures based on standard and
sequential additions of constituents to crushed tablets.
Eight modafinil products (from different batches) were
purchased from four websites. The eight products were
Table 2 Details of the powdered mixtures prepared
DN Modafinil tablet amount (mg) Diluent Diluent amount (mg) Total weight (mg) API (% m/m)
M1V1 201.3 LAC 0 201.3 62.5
M1V2 181.6 LAC 19.6 201.2 56.4
M1V3 168.5 LAC 32.6 201.1 52.4
M1V4 159.5 LAC 43.3 202.8 49.1
M1V5 151.2 LAC 53.1 204.3 46.2
M1V6 129 LAC 71.7 200.7 40.2
M1V7 110.9 LAC 90.6 201.5 34.4
M1V8 99.3 LAC 98.9 198.2 31.3
M1V9 81 LAC 119.9 201 25.2
M1V10 71.8 LAC 129.7 201.5 22.3
M1V11 50.8 LAC 150 200.8 15.8
M1V12 30.6 LAC 170.7 201.3 9.5
M1V13 0 LAC 199.6 199.6 0
M2V1 169.6 LAC/POV 30.6 200.2 52.9
M2V2 163 LAC/POV/MgS 52.4 215.4 47.3
M2V3 121.9 LAC/POV/MgS/MAI 79.4 201.3 37.8
M2V4 104.1 LAC/POV/MgS/MAI/MCC 97.2 201.3 32.3
M2V5 76.8 LAC/MCC/NaCMC 134.9 211.7 22.7
M2V6 51.8 LAC/POV/MgS/MAI/MCC/NaCMC 158.9 210.7 15.4
M3V1 201.3 0 0 201.3 62.5
M3V2 180.3 LAC 43.2 223.5 50.1
M3V3 134.4 POV 78.8 213.1 39.4
M3V4 100.7 MgS 97.2 197.8 31.8
M3V5 87.2 MAI 128 215.2 25.3
M3V6 71 MCC 149.1 220.1 20.2
M3V7 52.7 NaCMC 154.5 207.2 15.9
DN dilution number, M1 modafinil lactose dilution, M2 modafinil excipients dilution, M3 modafinil excipients sequential addition, LAC lactose, POV povidone, MgS
magnesium stearate, MAI maize starch, MCC microcrystalline cellulose, NaCMC sodium carboxymethylcellulose
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selected based on assessing the differences of authenti-
city of products between websites as well as within each
website. Four of these products had a label claim of
modafinil 100 mg; while the remaining four had a label
claim of modafinil 200 mg. The concentration range of
modafinil in the four products was 57.6–72.7% m/m
(Table 1). The tablets were compared in relation to the
major constituents (API and excipients) expected to be
present in branded and generic modafinil tablets.
Excipients present in branded modafinil tablets (Provigil)
include lactose monohydrate (main excipient), pregelati-
nised maize starch, croscarmellose sodium, povidone
K29/32 and magnesium stearate (Gold and Balster
1996). The excipient content of generic tablets may be
variable and not always known (Xu et al. 2002); there-
fore, additional excipients were measured including
glucose, maize starch, microcrystalline cellulose, sodium
carboxymethylcellulose and sucrose. The spectra of
modafinil tablets were compared to the spectra of the
API, excipient(s) and caffeine using the three techniques.
FTIR, NIR and Raman activity of modafinil tablets
Prior to spectral evaluation, the FTIR, NIR and Raman
activity of modafinil tablets and their main constituents
had been investigated. When comparing the three spec-
troscopic techniques in relation to medicines’ identifica-
tion, it is well known that APIs are more Raman active
whereas excipients are more IR/NIR active where the
Raman activity of excipients is often masked by fluores-
cence (Faisall et al. 2009). If the medicine contains high
concentrations of an excipient then the Raman activity
of the medicine could be masked by the fluorescence ex-
hibited by the excipient. One way of overcoming fluores-
cence of excipients was by using a longer wavelength
laser such as 1064 nm, and that had been adopted in the
current work.
The FTIR, NIR and Raman spectra of the medicinal
products were compared to those of the API (modafinil)
and the major excipient (lactose monohydrate) in moda-
finil tablets. Modafinil API was present in high amounts
in all of the measured products (57–72% m/m) which
minimised the effect of the excipients (Faisall et al.
2009). This was confirmed in the spectra of modafinil
products, its API and lactose using the three techniques
(Fig. 1). In this respect, the modafinil tablets’ spectra
showed representation of the modafinil API rather than
lactose. The FTIR spectrum of modafinil tablet (Fig. 1a)
showed higher similarity for the API spectrum (r = 0.95)
than the lactose spectrum (r = 0.82). Likewise the moda-
finil tablet NIR spectrum showed higher representation
for the API spectrum (r = 0.99) than lactose spectrum (r
= 0.77). The modafinil Raman spectrum showed higher
similarity for the API spectrum (r = 0.95) but dissimilar-
ity to the lactose spectrum (r = 0.01). This could be
attributed to the strong Raman activity of modafinil API
that had not been affected by the fluorescence of lactose.
Subsequently, the high representation of the API in the
tablets’ spectra contributed to the accuracy of quantifica-
tion of tablets. Crushing the tablets into powders was
needed to facilitate data collection, and while this
process may affect the physical properties of the powder
(such as the particle size), our observations showed that
the spectroscopic data were not affected in this particu-
lar case. Some properties such as polymorphic nature of
API are likely to be affected if strong physical processing
was applied; however, in our experiments, we had used
gentle processing to ensure minimal energy had been
applied to the tablets. Such delicate processing avoided
any polymorphic changes (such as recrystallisation or
amorphous formation). Hence reproducibility was not
affected by sample preparation.
PLSR model construction
PLSR was applied to the MSC-D1 FTIR, NIR and Raman
spectra over the full wavenumber/wavelength in each
technique. Four models were created using the FTIR
spectra and five models were created using the NIR and
Raman spectra (Table 3).
FTIR models included: FTIRM1 (modafinil lactose di-
lution), FTIRM2 (modafinil excipients dilution), FTIR
M3 (modafinil excipients sequential addition) and FTIR
M4 (modafinil powdered tablets model). FTIRM1, FTIR
M2 and FTIRM3 were constructed using a calibration
validation (C:V) ratio of 2:1. Moreover, the calibration
ranges used were 9.49–62.5, 15.4–52.9 and 15.9–62.5%
m/m, respectively. The modafinil powdered tablet model
(FTIRM4) was constructed with a C:V ratio of 3:1, four
factors and a range of 54.9–62.4% m/m.
NIR models included NIRM1 (modafinil lactose dilu-
tion), NIRM2 (modafinil excipients dilution), NIRM3
(modafinil excipients sequential addition), NIRM4 (mod-
afinil powdered tablets model) and NIRM5 (modafinil
intact tablet model). NIRM1, NIRM2 and NIRM3 were
constructed with a C:V ratio of 2:1 and had calibration
ranges of 9.49–62.5, 15.4–52.9 and 15.9–62.5% m/m, re-
spectively. In addition, NIRM4 and NIRM5 were created
with a C:V ratio of 3:1 and calibration range of 54.9–
62.5% m/m, respectively.
The Raman models used were RamanM1 (modafinil
lactose dilution), RamanM2 (modafinil excipients dilu-
tion), RamanM3 (modafinil excipients sequential
addition), RamanM4 (modafinil powdered tablets model)
and RamanM5 (modafinil intact tablet model).
RamanM1, RamanM2 and RamanM3 were made with a
C:V ratio of 2:1 and had calibration range of 9.49–62.5,
15.4–52.9 and 15.9–62.5% m/m, respectively. Further-
more, RamanM4 and RamanM5 were constructed with a
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C:V ratio of 3:1 and calibration range of 54.9–62.5% m/
m, respectively.
PLSR model validation
The linearity of the models was evaluated by internal val-
idation criteria calculated using the calibration and in-
ternal validation sets. For internal validation, the criteria
considered were the regression correlation coefficient (r2),
root mean square error of calibration (RMSEC) and root
mean square error of prediction (RMSEP) of the internal
validation set. The r2 and RMSEC were calculated by
interpreting the relationship between the predicted con-
centration and the nominal concentration of the calibra-
tion set. Likewise, the RMSEP was calculated by
interpreting the relationship between the predicted con-
centration and the nominal concentration of the
validation set. If the model was a good fit, the relationship
would be linear and an r2 value close to 1 would be ob-
tained. There was no optimal value for the RMSEC and
RMSEP; however, the lower they were, the more accurate
was the model. A more accurate judgement was made by
evaluating the relative standard error of prediction (RSEP),
which was calculated as the percentage of the ratio of
RMSEP to the mean value of the prediction set. A thresh-
old value of ± 5% was taken for RSEP.
For FTIR models, the highest accuracy was observed for
FTIRM1 (modafinil powdered tablet model), which
showed r2 values of 0.98 and 0.97 for the calibration and
validation sets, respectively (Table 2). FTIRM1 also
showed the high precision among the models with close
RMSEC and RMSEP values, which were 0.52 and 0.78%
m/m, respectively. Moreover, the RSEP value of FTIRM4
was 1.33%. The worst model in relation to accuracy and
precision among the FTIR models was FTIRM2. Thus,
this model showed very low r2 values which were 0.51 and
0.49 for both the calibration and validation sets, respect-
ively. Moreover, the model showed high RMSEC, RMSEP
and RSEP values of 11.2% m/m, 11.6% m/m and 29.8%, re-
spectively. This indicated that although the model was re-
peatable, it had low precision as the error values were not
satisfactory. Similarly, FTIRM3 (modafinil excipients dilu-
tion) showed close RMSEC and RMSEP values of 6.57 and
Fig. 1 MSCD1 treated (a) FTIR spectrum modafinil tablets. b FTIR spectrum of pure modafinil. c FTIR spectrum lactose monohydrate. d NIR
spectrum modafinil tablets. e NIR spectrum of pure modafinil. f NIR spectrum lactose monohydrate. g Raman spectrum modafinil tablets. h
Raman spectrum of pure modafinil. i Raman spectrum lactose monohydrate measured using the Bruker Alpha FTIR, JDSU microNIR and Rigaku
handheld Raman instruments, respectively
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4.63% m/m, respectively; yet, high RSEP value of 13.55%.
FTIRM3 showed low accuracy of calibration with r2 value
of 0.75. The same pattern was observed with FTIRM4 that
had close values of RMSEC (6.29% m/m) and RMSEP
(7.03% m/m) and high RSEP value (19.8%). The lower ac-
curacy in models based on mixtures rather than tablets
could be attributed to the small amount of measurements
(few milligrams) taken per sample. In this respect, the
higher the complexity of the sample (as the case of pow-
dered tablets), the more representation of the sample was
in the FTIR spectrum.
NIR models showed the highest accuracy for NIRM3
(modafinil excipients sequential addition) which gave r2
values for the calibration and validation sets of 0.99 and
0.99, respectively (Table 3). NIRM3 showed high preci-
sion with RMSEC and RMSEP values of 1.15 and 1.21%
m/m correspondingly. Moreover, it showed an RSEP
value of 3.45%. Additionally, the two tablet-based models
showed high precision but slightly lower accuracy than
NIRM3. These included NIRM4 (modafinil powdered
tablet model) and NIRM5 (modafinil intact tablet model)
which had r2 values of calibration of 0.77 and 0.69 indi-
vidually. Both models were highly precise and showed
RMSEC values below 2% m/m and RSEP values below
4%. The remaining two powder models (NIRM1 and
NIRM2) showed slightly lower accuracy but very poor
precision. Thus, the r2 values of calibration for NIRM1
(modafinil lactose dilution) and NIRM2 (modafinil ex-
cipients dilution) were 0.72 and 0.84. Both of these
models showed good repeatability with very close RMSE
C and RMSEP values. Thus, NIRM1 showed RMSEC
and RMSEP values of 8.45 and 8.82% m/m, respectively.
Likewise, NIRM2 showed RMSEC and RMSEP values of
5.26 and 5.25% m/m but had very poor external preci-
sion in the range of 15–23%.
Raman models showed the highest accuracy/precision
for RamanM4 (modafinil powdered tablet model) and
Raman M5 (modafinil intact tablet model) (Table 3).
The aforementioned two models showed r2 value of cali-
bration of 0.98 and 0.94. In addition, the RMSEC and
RMSEP values for RamanM4 were 0.54 and 0.82% m/m,
whereas for RamanM5, these values were 0.96 and 0.91%
m/m, respectively. RamanM4 provided a more precise
model as it showed ten times lower RSEP value (1.4%)
than RamanM5 (12.1%). The models based on powdered
mixtures gave lower accuracy and precision than tablet-
based models. In this sense, RamanM1 (modafinil
lactose dilution), RamanM2 (modafinil excipients
dilution) and RamanM3 (modafinil excipients sequential
addition) had low r2 values of calibration which were
0.70, 0.84 and 0.76, respectively. The three aforemen-
tioned models had high RSEP values which were in the
range of 17–24%. All three models showed close
agreement between their RMSEC and RMSEP values
(Table 3).
Prediction of modafinil in generic tablets
Test sets of powdered and intact tablets were used to
examine the external predictive ability of the models.
The predicted value was converted into label claim, and
the percentage label claim of each product was assessed.
The pharmacopoeia acceptable deviation of the API for
tablets is usually ± 5% of the label claim in order to
allow variation in production, degradation during shelf
Table 3 Results of the PLSR models constructed using the three techniques
Modelnumber F C:V ratio r2calib RMSEC (% m/m) r2 valid RMSEP (% m/m) RSEP (%)
FTIRM1 3 25:11 0.98 0.52 0.97 0.78 1.33
FTIRM2 1 12:60 0.51 11.24 0.49 11.61 29.9
FTIRM3 1 14:70 0.75 6.57 0.93 4.63 16.5
FTIRM4 4 60:20 0.84 6.29 0.80 7.03 19.8
NIRM1 1 25:11 0.72 8.45 0.70 8.82 23.3
NIRM2 1 12:60 0.84 5.26 0.84 5.25 15.2
NIRM3 3 14:70 0.99 1.15 0.99 1.21 3.45
NIRM4 1 60:20 0.77 1.77 0.69 2.05 3.51
NIRM5 1 48:16 0.69 1.91 0.76 1.71 2.85
RamanM1 1 25:11 0.70 8.49 0.80 6.74 19.0
RamanM2 1 12:60 0.84 5.52 0.83 6.57 17.8
RamanM3 1 14:70 0.76 7.62 0.83 9.16 23.9
RamanM4 4 60:20 0.98 0.54 0.95 0.82 1.40
RamanM5 4 48:16 0.94 0.96 0.93 0.91 12.1
FTIRM1, NIRM1 and RamanM1 modafinil lactose dilution; FTIRM2, NIRM2 and RamanM2 modafinil excipients dilution; FTIRM3, NIRM3 and RamanM3 modafinil
excipients sequential addition; FTIRM4, NIRM4 and RamanM4 modafinil powdered tablets model; NIRM5 and RamanM5 modafinil intact tablet model; C:V
calibration:validation ratio; F number of factors, r2 correlation coefficient, RMSE:root mean square error
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life of the product and accuracy of the analytical
method. In this work, the range was extended to ± 30%
of the label claim to compensate for difficulty in setting
up a calibration in the spectra and account for the noise
generated by the instrument/spectral algorithms
(Young-Powell and Page 2014).
For powdered tablets, all the eight products were pre-
dicted through the powdered dilution models (Table 4).
In this respect, the best predictive ability was observed
for NIRM3 which showed a mean prediction of 98.2%
label claim (RSD = 2.35%) for all batches. This was
followed by FTIRM3 and NIRM1, which showed mean
prediction values of 97.9 and 97.2% label claim, respect-
ively. Additionally, FTIRM2 and NIRM2 showed good
predictive ability with values of 91.1 and 90.2% label
claim, respectively. The remaining models (FTIRM1,
RamanM1, RamanM2 and RamanM3) exhibited poor
predictive ability below 70%.
RamanM2 and RamanM3 showed better prediction for
intact tablets (Table 5). Thus, the mean prediction of in-
tact tablets using the two models were 108 and 84%
label claim, respectively. Moreover, NIRM2 showed good
predictive ability for intact tablets with a mean predic-
tion of 103% label claim. The remaining models included
NIRM1, NIRM3 and RamanM1 had poor prediction
above 130% label claim.
Conclusions
The findings demonstrated that the combination of
handheld FTIR, NIR and Raman spectroscopy with PLSR
offered a rapid method for quantifying modafinil in
branded generic medicines with minimal sample prepar-
ation. NIR and Raman techniques were non-destructive;
however, FTIR required powdering the tablets prior to
measurement. In comparison to NIR, FTIR and Raman
showed that models based on tablets were more accurate
than those based on powder mixtures. Among the
powder mixture models, modafinil excipients sequential
addition offered the highest accuracy and precision for
the quantification of powdered tablets using FTIR and
NIR spectroscopy. Modafinil excipient dilution models
offered the highest accuracy and precision for the
quantification of intact tablets using NIR and Raman
spectroscopy. Consequently, the choice of the powder
model depended to a degree, on the technique used as
well as the sample quantified. Subsequently, this may
represent a challenge in the generalisability of the
method to other nootropics that could be of different
concentration and have different formulation. Hence, fu-
ture work should consider the accuracy of quantification
for different formulation types (tablets, capsules, caplets)
and/or closely related analogues of drugs.
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Table 4 Results of the predicted powdered tablets
BN Predicted label claim (%)
1a 1b 2a 2b 3a 3b 4a 4b
Dose (mg) 100 100 200 200 200 200 100 100
FTIRM1 24.9 57.7 49.4 43.8 70.2 49.4 28.1 42.6
FTIRM2 98.5 96.4 86.8 87.8 88.0 87.5 91.2 92.9
FTIRM3 105 104 93.1 94.1 94.6 93.9 98.4 100
NIRM1 100 98.6 95.3 95.2 95.9 93.4 101 98.3
NIRM2 92.0 89.5 88.8 88.4 89.6 87.1 94.4 91.4
NIRM3 97.6 94.7 99.2 99.2 101 96.9 101 96.0
RamanM1 91.1 60.7 55.4 55.8 56.0 55.2 59.1 60.6
RamanM2 74.0 46.2 44.9 44.9 44.9 44.5 46.7 48.7
RamanM3 80.6 65.9 64.0 63.2 65.8 64.0 67.5 68.4
BN batch number
Table 5 Results of the predicted intact tablets
BN Predicted label claim (%)
2a 2b 3a 3b 4a 4b
Dose (mg) 200 200 200 200 100 100
NIRM1 134 135 137 136 133 133
NIRM2 107 107 108 110 95.4 89.1
NIRM3 144 145 148 150 125 118
RamanM1 186 188 170 182 205 210
RamanM2 101 106 97.6 104 119 122
RamanM3 77.9 81.0 72.5 77.7 94.5 100.9
BN batch number
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